首页> 外文期刊>Nature Communications >Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila
【24h】

Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila

机译:磷酸依赖的泛素化和PAR-1的降解调节果蝇中的突触形态和tau介导的Aβ毒性。

获取原文
           

摘要

The conserved kinases PAR-1/MARK are critically involved in processes such as asymmetric cell division, cell polarity and neuronal differentiation. Their deregulation has been implicated in diseases including Alzheimer’s disease and cancer. Given the importance of PAR-1/MARK in health and disease, their activities need to be tightly controlled. However, little is known about the molecular mechanisms underlying their regulation in vivo. Here we show that in Drosophila, a phosphorylation-dependent ubiquitination mechanism restrains PAR-1 activation. Active PAR-1 generated by LKB1-controlled phosphorylation is targeted for ubiquitination and degradation by SCF (Skp, Cullin, F-box containing complex) (Slimb), whose action is antagonized by the deubiquitinating enzyme fat facets. This newly identified PAR-1-modifying module critically regulates synaptic morphology and tau-mediated postsynaptic toxicity of amyloid precursor protein (APP)/Aβ-42, the causative agents of Alzheimer’s disease, at the Drosophila neuromuscular junction. Our results provide new insights into the regulation of PAR-1 in various physiological processes and offer new therapeutic strategies for diseases involving PAR-1/MARK deregulation.. ? 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
机译:保守的激酶PAR-1 / MARK关键参与诸如不对称细胞分裂,细胞极性和神经元分化的过程。他们的放松管制与阿尔茨海默氏病和癌症等疾病有关。鉴于PAR-1 / MARK在健康和疾病中的重要性,需要严格控制其活动。但是,对其体内调节的分子机制了解甚少。在这里,我们显示在果蝇中,磷酸化依赖性泛素化机制抑制PAR-1激活。由LKB1控制的磷酸化产生的活性PAR-1被SCF(Skp,Cullin,F-box含复合物)(Slimb)靶向进行泛素化和降解,其作用被去泛素化酶脂肪小体拮抗。这个新近鉴定出的PAR-1修饰模块可在果蝇神经肌肉连接处严格调节阿尔茨海默氏病病原体淀粉样前体蛋白(APP)/Aβ-42的突触形态和tau介导的突触后毒性。我们的结果为各种生理过程中PAR-1的调控提供了新的见识,并为涉及PAR-1 / MARK失调的疾病提供了新的治疗策略。 2012自然出版集团,麦克米伦出版社有限公司的一个部门。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号